Appointment booking for Dr. Charles Goddard, MD is currently not available.Dr. Charles Goddard, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Charles Goddard, MD (he/him) is a Pediatrician in Dublin, OH with over 17 years of experience. What is your opinion of Dr. Charles Goddard, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 17 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Charles Goddard, MD has received over $1,185 which includes payments from the following companies:
$190.91 from Ironshore Pharmaceuticals Inc.
$138.70 from GlaxoSmithKline, LLC.
$125.00 from Meda Pharmaceuticals, Inc.
$109.61 from Rhodes Pharmaceuticals L.P.
$99.53 from Phadia US Inc.
$74.10 from Takeda Pharmaceuticals U.S.A., Inc.
$72.94 from Pfizer Inc.
$63.18 from Shire North American Group Inc
$59.26 from Lupin Pharmaceuticals, Inc
$45.93 from Neos Therapeutics, LP
$42.98 from Tris Pharma Inc
$38.80 from Merck Sharp & Dohme Corporation
$32.22 from Cranial Technologies, Inc
$23.45 from Amneal Pharmaceuticals LLC
$17.13 from Smith & Nephew, Inc.
$16.27 from MedImmune, LLC
$12.43 from Vertical Pharmaceuticals, LLC
$12.35 from QIAGEN Sciences LLC
$10.41 from FSC Laboratories, Inc.
Payments received by Dr. Charles Goddard, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!